Related Experiment Videos
Complementary DNA for a human subgroup IV immunoglobulin lambda-chain
N Yamasaki1, S Komori, T Watanabe
1Department of Molecular Immunology, Kyushu University, Fukuoka, Japan.
Molecular Immunology
|September 1, 1987
Summary
Researchers cloned a human immunoglobulin lambda-chain gene (V lambda 3C4) crucial for a monoclonal antibody targeting sperm antigens. This gene family has multiple related members in the human genome, with variations observed in individuals.
Area of Science:
- Immunogenetics
- Molecular Biology
Background:
- Human monoclonal antibodies are vital tools in diagnostics and therapeutics.
- Understanding the genetic basis of antibody production, particularly immunoglobulin lambda-chains, is essential.
Purpose of the Study:
- To clone and characterize the cDNA encoding a human immunoglobulin lambda-chain (V lambda 3C4) from a hybridoma producing an antibody against a human sperm surface antigen.
- To investigate the genetic organization and variability of the V lambda IV subgroup genes in the human genome.
Main Methods:
- cDNA cloning of the immunoglobulin lambda-chain.
- Nucleotide sequencing and amino acid sequence deduction.
- Southern blot analysis of human genomic DNA.
- Restriction enzyme fragment length polymorphism (RFLP) analysis.
Main Results:
- Successfully cloned the p3C4 lambda 5 cDNA encoding the V lambda 3C4 lambda-chain.
- The deduced amino acid sequence of V lambda 3C4 showed high relatedness to SHV lambda protein (subgroup IV).
- Southern blot analysis identified at least 8 cross-hybridizing genes belonging to the V lambda IV subgroup.
- RFLP analysis indicated the presence of genetic polymorphism in the V lambda 3C4 gene among normal individuals.
Conclusions:
- The cloned V lambda 3C4 gene is a member of the human immunoglobulin lambda-chain subgroup IV.
- The V lambda IV subgroup is represented by multiple genes in the human genome.
- Genetic variations within the V lambda 3C4 gene locus exist in the human population, potentially influencing antibody diversity.